Clinical Trial Update: Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing microneedle lesion preparation before ALA-PDT for actinic keratosis on the face; results completed and posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• ALA-PDT (5-aminolevulinic acid–mediated photodynamic therapy)
• aminolevulinic acid photodynamic therapy (aminolevulinic acid photodynamic therapy)

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2017-12-13